Magnetically controlled thrombolytic passed preclinical trials
ITMO University scientists have used nanoparticles and magnetic waves to localise drug delivery in animal models, resulting in no side effects...
List view / Grid view
ITMO University scientists have used nanoparticles and magnetic waves to localise drug delivery in animal models, resulting in no side effects...
A research team has developed a nano-platform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma...
Gold nanoparticles carried Cas9 enzyme into brain, editing receptor and lessening burying behaviour...
Non-small cell lung cancer Nanoparticles pass the next stage of development in preclinical tests...
Researchers developed an approach and platform to create large amounts of fillable and targeted nanovesicles to deliver drugs to tumours in mice...
In its 10th year, the Adaptive Designs in Clinical Trials conference returns to central London in April 2018...
Our agenda is packed with keynote addresses, expert speakers, informative content and senior figures from within the industry…read on to find out more…
By chipping away at a viral protein, Rice University scientists have discovered a path toward virus-like, nanoscale devices that may be able to deliver drugs to cells.
While attempting to position two chips on a microscope, an involuntary exhalation by scientist Greg Madejski caused them to adhere to great effect.
Polymer nanoagents that can ‘light up’ tiny areas of diseased tissues that conventional methods fail to detect, have been created by a research team led by NTU Singapore.
Gold nanoparticles have been shaped to improve their properties in biomedicine and photonics by using a special laser system...
A new biomedical tool has been developed using nanoparticles that deliver transient gene changes to targeted cells...
Nemus Bioscience announced that THC derived from NB1111 achieved significant tissue concentrations in multiple compartments of the eye...
The DFG has agreed to fund the Mainz-based Collaborative Research Center involved in the development of nanomaterials for cancer immunotherapy...
A new diagnostic will allow men to bypass painful biopsies to test for aggressive prostate cancer.